Predict your next investment

Corporation
HEALTHCARE | Biotechnology
tibotec-virco.com

See what CB Insights has to offer

Founded Year

1994

Stage

Acquired | Acquired

Total Raised

$72.14M

About Tibotec, Virco

Developer of new drugs, innovative treatment solutions and practical disease management tools for HIVAIDS and hepatitis C. The company is focusing on the discovery and development of HIV/AIDS compounds that are active against both wild-type HIV and strains of HIV that have developed drug resistance. HIV drug resistance is a major cause of treatment failure.

Tibotec, Virco Headquarter Location

Mechelen Noord, Zone L, Gen de Wittelaan 11 B 3

Mechelen, 2800,

Belgium

32 1 528 63 00

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Tibotec, Virco Patents

Tibotec, Virco has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/9/2007

7/12/2011

Molecular biology, Animal virology, Virology, Animal viral diseases, Gene expression

Grant

Application Date

3/9/2007

Grant Date

7/12/2011

Title

Related Topics

Molecular biology, Animal virology, Virology, Animal viral diseases, Gene expression

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.